Score Overview
Explore the 2021 public Archive ranking β
Where MiMedx Group Inc has ranked, year by year
Showing 10 years ranking history by Net Income Growth.
Has not reached the top 50 on Net Income Growth in any year we have ranked.
- MDXG
2019: 83.9% Β· 2021: 87.6% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-22 | $ 3.93 | β |
1 Year2025-10-22 | $ 6.72 | -41.52% |
5 Years2021-10-22 | $ 7.03 | -44.10% |
10 Years2016-10-21 | $ 8.48 | -53.66% |
All Time2007-08-22 | $ 0.10 | 39x |
| Period | Last Price2026-10-22 | 1 Year2025-10-22 | 5 Years2021-10-22 | 10 Years2016-10-21 | All Time2007-08-22 |
|---|---|---|---|---|---|
| Price | $ 3.93 | $ 6.72 | $ 7.03 | $ 8.48 | $ 0.10 |
| Return | β | -41.52% | -44.10% | -53.66% | 39x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 355M | $ 6M | $ 135M |
| 2025 | $ 418M | $ 48M | $ 166M |
| 2024 | $ 348M | $ 42M | $ 104M |
| 2023 | $ 321M | $ 67M | $ 82M |
| 2022 | $ 267M | -$ 30M | $ 65M |
| 2021 | $ 242M | -$ 12M | $ 87M |
| 2020 | $ 248M | -$ 49M | $ 95M |
| 2019 | $ 359M | -$ 29M | $ 45M |
| 2018 | $ 359M | -$ 29M | $ 45M |
| 2017 | $ 321M | $ 64M | $ 27M |
| 2016 | $ 245M | $ 11M | $ 34M |
| 2015 | $ 187M | $ 29M | $ 31M |
| 2014 | $ 118M | $ 6M | $ 52M |
| 2013 | $ 59M | -$ 4M | $ 44M |
| 2012 | $ 27M | -$ 7M | $ 6M |
| 2011 | $ 7M | -$ 10M | $ 4M |
| 2010 | $ 788.87K | -$ 11M | $ 1M |
| 2009 | -$ 11M | $ 2M | |
| 2008 | -$ 17M | $ 6M | |
| IPO2007 | $ 184.00 |

MiMedx Group Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 248M to $ 418M and net income went from -$ 49M to $ 48M. Revenue increased in 4 of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 187M to $ 418M and net income grew from $ 29M to $ 48M. Revenue increased in 6 of those 10 years; net income in 4.
MiMedx Group Inc currently holds a 5-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.
Membership
Continue MDXGβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Schrodinger IncSDGRΒ· revenue grew in 80% of years- INDVIndivior PLC Ordinary SharesINDVΒ· revenue grew in 100% of years
Puma Biotechnology IncPBYIΒ· revenue grew in 40% of years
Dr. Reddyβs Laboratories Ltd ADRRDYΒ· revenue grew in 80% of years
GlaxoSmithKline PLC ADRGSKΒ· revenue grew in 100% of years